Children’s Cancer

Led by Dr Quentin Campbell-Hewson

Great North Children’s Hospital Newcastle, UK

About Quentin

Dr Quentin Campbell-Hewson has been a Paediatric Oncologist in Newcastle for the last 14 years. He is the lead for Chemotherapy Services, the Solid Tumour service, and the Early Phase Trial service. He is also the NIHR Clinical research Network lead for the North of England and North Cumbria. He is a very active researcher, and is Chief Investigator on 2 open studies and Principal investigator on eleven others. He jointly established and leads the INCLuDE network encompassing the North of England, Scotland and Northern Ireland, which identifies children who need novel therapies for cancer and facilitating trial delivery across this network. This network has become the template for the rest of the UK. He is the Newcastle lead for the paediatric UK Paediatric Experimental Cancer Medicines Centre network and the European Innovative Therapies in Childhood cancer network.

About Children’s Cancer

This theme will initially be exploring 3 sub themes related to children’s cancer. These were identified principally following discussions with our patients and their parents and families but also in collaboration with the multidisciplinary team at Newcastle as well as the Children’s Cancer and Leukaemia Group which is the national body for Children’s malignancy in the UK. The sub themes are

  • Information exchange: information technology applications to inform, guide, assist and record the care of children and young people when receiving care away from the principal treatment centre. This will be piloted as an application to guide and record medication dosage and care for children with Leukaemia in the first instance
  • Clinical Monitoring: More efficient, convenient and effective mechanisms for the monitoring of vital signs particularly temperature when out of hospital. In particular there will be an emphasis on wearable remote recording devices
  • Care and protection of indwelling devices in children’s cancer patients: More effective technologies for the securing, care and protection of indwelling central catheters and other medical devices such as nasogastric tubes, gastrostomies, or other indwelling devices. The emphasis here is to enable more normal life for children who require to have these devices.

Get Involved

Do you have an unmet need? Would you like to collaborate with Quentin?